Baby Safety / Compounds / Amygdalin (cyanogenic glycosides)

Is Amygdalin (cyanogenic glycosides) safe for babies and kids?

High risk for kids

Infants are highly susceptible to Amygdalin (cyanogenic glycosides) due to lower body weight, immature detoxification pathways, and dietary exposure through contaminated grains or breast milk.

What is amygdalin (cyanogenic glycosides)?

The IUPAC name is (2R)-2-phenyl-2-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxyacetonitrile.

Also known as: (2R)-2-phenyl-2-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxyacetonitrile, amygdalin, (R)-Amygdalin, D-Amygdalin.

IUPAC name
(2R)-2-phenyl-2-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxyacetonitrile
CAS number
29883-15-6
Molecular formula
C20H27NO11
Molecular weight
457.4 g/mol
SMILES
C1=CC=C(C=C1)C(C#N)OC2C(C(C(C(O2)COC3C(C(C(C(O3)CO)O)O)O)O)O)O
PubChem CID
656516

Risk for babies

High risk

Infants are highly susceptible to Amygdalin (cyanogenic glycosides) due to lower body weight, immature detoxification pathways, and dietary exposure through contaminated grains or breast milk.

Neonates and infants up to 12 months have incomplete blood-brain barrier development, immature Phase I/II metabolic enzymes (particularly CYP3A4, UGT1A1), and higher gastrointestinal permeability. Equivalent doses produce higher internal concentrations and longer residence times.

What to do: Minimize infant exposure through source control. For breastfeeding mothers: reduce maternal exposure. For formula-fed infants: use certified low-migration bottles and verified water sources. Consult pediatrician regarding any concerns.

Risk for pregnant and nursing people

Context-dependent

Pregnancy alters the metabolism and distribution of Amygdalin (cyanogenic glycosides), potentially increasing fetal exposure. The developing embryo/fetus is vulnerable during organogenesis (weeks 3-8) and neurological development. Placental transfer should be assumed.

No specific reproductive toxicity data identified, but pregnancy-specific safety data is limited for most chemicals. Precautionary minimization of exposure is recommended.

What to do: Minimize exposure during pregnancy and lactation. Consult healthcare provider regarding specific risks. Consider alternative products with lower hazard profiles.

Regulatory consensus

1 regulatory bodyhas classified Amygdalin (cyanogenic glycosides).

AgencyYearClassificationNotes
FDA1977Import Alert - laetrile importation banned

Regulators apply different standards of evidence — animal-data weighting, exposure-pattern assumptions, epidemiological power thresholds — which is why two scientific bodies can review the same data and reach different conclusions. The disagreement is the data.

Where kids encounter amygdalin (cyanogenic glycosides)

  • Industrial Facilities — Manufacturing plants, Chemical storage areas, Waste treatment sites
  • Occupational Environments — Factories, Warehouses, Transportation vehicles

Safer alternatives

Lower-risk approaches that achieve a similar outcome to Amygdalin (cyanogenic glycosides):

  • Avoidance (no chemical substitute)
    Trade-offs: Direct chemical substitution requires verification that the replacement does not introduce new hazards (regrettable substitution). Conduct full hazard assessment of proposed alternative before adoption.
    Relative cost: 1.2-2×

Frequently asked questions

Is amygdalin (cyanogenic glycosides) safe for kids?

Infants are highly susceptible to Amygdalin (cyanogenic glycosides) due to lower body weight, immature detoxification pathways, and dietary exposure through contaminated grains or breast milk.

What products contain amygdalin (cyanogenic glycosides)?

Amygdalin (cyanogenic glycosides) appears in: Manufacturing plants (Industrial facilities); Chemical storage areas (Industrial facilities); Factories (Occupational environments); Warehouses (Occupational environments).

What should I do if my child is exposed to amygdalin (cyanogenic glycosides)?

Minimize infant exposure through source control. For breastfeeding mothers: reduce maternal exposure. For formula-fed infants: use certified low-migration bottles and verified water sources. Consult pediatrician regarding any concerns.

See Amygdalin (cyanogenic glycosides) in the baby app

Look up products containing amygdalin (cyanogenic glycosides), compare to alternatives, and explore the full data record.

Open in baby View raw API data

Sources (2)
  1. US FDA: Amygdalin (Laetrile/Vitamin B17) — Import Alert, Fraudulent Cancer Treatment, and Cyanide Poisoning Risk from High-Dose Supplemental Use (1977, updated 2006) (2006) — regulatory
  2. ASPCA Animal Poison Control Center: Cyanogenic Glycosides (Amygdalin, Prunasin) — Rosaceae Fruit Pit and Apple Seed Toxicity in Dogs and Cats, HCN Mechanism, and Clinical Cases (2019) — veterinary

Reference data, not professional advice. Aggregates publicly available regulatory and scientific data; not a substitute for veterinary, medical, legal, or regulatory advice. Why we built ALETHEIA →